3030 — Test Research Cashflow Statement
0.000.00%
- TWD47.60bn
- TWD45.46bn
- TWD6.36bn
- 75
- 28
- 79
- 68
Annual cashflow statement for Test Research, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,373 | 1,558 | 2,454 | 1,255 | 2,178 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -10.4 | -13.3 | -8.51 | -31.6 | -8.86 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -371 | -1,091 | -1,119 | 511 | -1,197 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,120 | 591 | 1,467 | 1,878 | 1,160 |
Capital Expenditures | -52.6 | -155 | -680 | -877 | -389 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -3.93 | 46.7 | -74.6 | -181 | 19 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -56.5 | -108 | -754 | -1,058 | -370 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -806 | -807 | -814 | -1,098 | -814 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 260 | -335 | -77.7 | -289 | 13.7 |